These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19409288)

  • 1. Prominin1 (CD133) as an intestinal stem cell marker: promise and nuance.
    Montgomery RK; Shivdasani RA
    Gastroenterology; 2009 Jun; 136(7):2051-4. PubMed ID: 19409288
    [No Abstract]   [Full Text] [Related]  

  • 2. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.
    Zhu L; Gibson P; Currle DS; Tong Y; Richardson RJ; Bayazitov IT; Poppleton H; Zakharenko S; Ellison DW; Gilbertson RJ
    Nature; 2009 Jan; 457(7229):603-7. PubMed ID: 19092805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.
    Snippert HJ; van Es JH; van den Born M; Begthel H; Stange DE; Barker N; Clevers H
    Gastroenterology; 2009 Jun; 136(7):2187-2194.e1. PubMed ID: 19324043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An update: stem cell and cancer stem cells].
    Liu YQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):511-2. PubMed ID: 20021959
    [No Abstract]   [Full Text] [Related]  

  • 5. CD133: molecule of the moment.
    Mizrak D; Brittan M; Alison M
    J Pathol; 2008 Jan; 214(1):3-9. PubMed ID: 18067118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD133 in synovial sarcoma.
    Terry J; Nielsen T
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):159-65. PubMed ID: 19752721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CD133 antigen in cancer.
    Ferrandina G; Petrillo M; Bonanno G; Scambia G
    Expert Opin Ther Targets; 2009 Jul; 13(7):823-37. PubMed ID: 19530986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133 as a marker for cancer stem cells: progresses and concerns.
    Wu Y; Wu PY
    Stem Cells Dev; 2009 Oct; 18(8):1127-34. PubMed ID: 19409053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of putative pancreatic progenitor cells from mice by sorting for prominin1 (CD133) and platelet-derived growth factor receptor beta.
    Hori Y; Fukumoto M; Kuroda Y
    Stem Cells; 2008 Nov; 26(11):2912-20. PubMed ID: 18703663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
    Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A
    J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilizing stem cells to repair liver after surgery: dream or reality?
    Mallet VO; Gilgenkrantz H
    J Hepatol; 2005 Nov; 43(5):754-6. PubMed ID: 16171889
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to communication of Paola Romagnani and Giuseppe Remuzzi.
    Perego RA; Bombelli S
    Stem Cell Res; 2014 May; 12(3):830-1. PubMed ID: 24480083
    [No Abstract]   [Full Text] [Related]  

  • 13. CD133 is a marker of bioenergetic stress in human glioma.
    Griguer CE; Oliva CR; Gobin E; Marcorelles P; Benos DJ; Lancaster JR; Gillespie GY
    PLoS One; 2008; 3(11):e3655. PubMed ID: 18985161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?
    Neuzil J; Stantic M; Zobalova R; Chladova J; Wang X; Prochazka L; Dong L; Andera L; Ralph SJ
    Biochem Biophys Res Commun; 2007 Apr; 355(4):855-9. PubMed ID: 17307142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.
    Wang M; Xiao J; Jiang J; Qin R
    Int J Cancer; 2011 Apr; 128(8):1996-7. PubMed ID: 20568110
    [No Abstract]   [Full Text] [Related]  

  • 16. Insight into the complex regulation of CD133 in glioma.
    Campos B; Herold-Mende CC
    Int J Cancer; 2011 Feb; 128(3):501-10. PubMed ID: 20853315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.
    Bartling B; Koch A; Simm A; Scheubel R; Silber RE; Santos AN
    Int J Mol Med; 2010 Jan; 25(1):89-96. PubMed ID: 19956906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent.
    Sun Y; Kong W; Falk A; Hu J; Zhou L; Pollard S; Smith A
    PLoS One; 2009; 4(5):e5498. PubMed ID: 19430532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha2,3-Sialylation regulates the stability of stem cell marker CD133.
    Zhou F; Cui C; Ge Y; Chen H; Li Q; Yang Z; Wu G; Sun S; Chen K; Gu J; Jiang J; Wei Y
    J Biochem; 2010 Sep; 148(3):273-80. PubMed ID: 20551139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.